高血压疾病患者血清同型半胱氨酸和超敏C反应蛋白水平的变化及意义

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To explore the changes and significance of serum homocysteine and high-sensitivity C-reactive protein in patients with hypertension.Methods A total of 100 patients with hypertension admitted to the Shaoguan Institute of Occupational Disease Control from February 1,2015 to February 10,2016 were selected as the observation group (according to their different degrees of disease,they were divided into mild [30 cases],moderate [30 cases] and severe [40 cases]).In addition,100 healthy subjects were selected as the control group.The levels of serum homocysteine and high-sensitivity C-reactive protein of subjects in two groups were measured,and the levels of subjects in the two groups were analyzed..Results Serum homocysteine and high-sensitivity C-reactive protein levels in the observation group were higher than those in the control group,the differences were statistically significant (P<0.05).Serum homocysteine and high-sensitivity C-reactive protein levels in severe patients were higher than those in mild and moderate patients,serum homocysteine and high-sensitivity C-reactive protein levels in moderate patients were higher than those in mild patients,the differences were statistically significant (P<0.05).Conclusion Serum homocysteine and high-sensitivity C-reactive protein are closely related to the development of hypertension,which can reflect the severity of hypertension,provide a favorable basis for the later treatment of hypertension,and is worthy of promotion and application in clinical.

Key words： Serum homocysteine High-sensitivity C-reactive protein Hypertension

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LI Ying
	ZENG Xiu-ping
	XIE Shu-ying

Cite this article:

LI Ying,ZENG Xiu-ping,XIE Shu-ying. Changes and significance of serum homocysteine and hypersensitive Creactive protein in patients with hypertension[J]. 中国当代医药, 2020, 27(36): 171-173.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2020/V27/I36/171

[1]	公志华，杨云，周永年，等.太原地区体检人群血清同型半胱氨酸调查研究[J].中国药物与临床，2019，19（2）：229-230.
[2]	王继光，程艾邦.血压130～139/80～89 mmHg 不能轻视[J].中华心血管病杂志，2018，46（9）：672-674.
[3]	Olsson KM，Delcroix M，Ghofrani HA，et al.Anticoagulation and survival in pulmonary arterial hypertension：.Results from the comparative，prospective registry of newly initiated therapies for pulmonary hypertension（COMPERA）[J].Circulation，2014，129（1）：57-65.
[4]	付莎，徐安平，梁佩芬，等.狼疮性肾炎患者血清高敏C反应蛋白与疾病活动度及心血管危险因素的相关性[J].广东医学，2014，35（20）：3196-3198.
[5]	吴芦英，吕亚儿.妊娠期高血压疾病患者血清同型半胱氨酸、超敏C反应蛋白和尿β2 微球蛋白水平及临床意义[J].中国妇幼保健，2016，31（11）：2266-2268.
[6]	高立功，谭文刚.血清IL-6、hs-CRP、Lep、E2及神经功能相关指标在老年高血压脑出血患者中的检测价值[J].海南医学院学报，2014，20（3）：334-336.
[7]	颜冬，李艳，王琪，等.妊娠高血压疾病患者胱抑素C、超敏C反应蛋白及同型半胱氨酸水平的变化及其诊断价值分析[J].湖南师范大学学报（医学版），2018，15（3）：75-77.
[8]	耿辉，魏雁虹，宋帅等.α1-微球蛋白、C-反应蛋白、D-二聚体联合检验在妊娠期高血压疾病诊疗中的意义[J].中国妇幼保健，2017，32（9）：1847-1849.
[9]	植奇升，冯彩莲，植瑞彬，等.同型半胱氨酸浓度与高血压相关性的研究[J].临床检验杂志（电子版），2019，8（3）：37-38.
[10]	熊克平.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效及安全性[J].世界最新医学信息文摘，2018，18（26）：122，124.
[11]	王霞.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的临床疗效观察[J].中国社区医师，2017，33（2）：11-12.
[12]	刘俊川.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效[J].临床研究，2017，25（11）：21-23.
[13]	江培猛，朱志德，李经毅，等.氨氯地平联合阿托伐他汀钙片治疗高血压合并冠心病的临床效果观察[J].中国医药科学，2017，7（3）：97-99.
[14]	王萍.氨氯地平阿托伐他汀钙片治疗高血压合并冠心病的疗效观察[J].中国现代药物应用，2017，11（4）：86-87.
[15]	郭薇，安源，方乐，等.血清超敏C-反应蛋白、同型半胱氨酸、尿酸水平与非致残性缺血性脑血管事件患者关系研究[J].中国实验诊断学，2019，23（9）：1583-1584.
[16]	郑向萍.血清同型半胱氨酸水平与高血压病的相关性分析[J].饮食保健，2018，5（19）：58.